Table 1.
Demographic characteristics of patients examined by ColoDefense test
| Group | Characteristics | Number of patients | |
|---|---|---|---|
| Tissue | CRC and adjacent paracancerous tissue (n = 40) | Gender (%) | |
| Male | 23 (57.5) | ||
| Female | 17 (42.5) | ||
| Age | |||
| Mean (min‐max) | 57.4 (33‐78) | ||
| Medium | 58 | ||
| Adenomatous polyp (n = 10) | Gender (%) | ||
| Male | 7 (70.0) | ||
| Female | 3 (30.0) | ||
| Age | |||
| Mean (min‐max) | 56 (24‐80) | ||
| Medium | 59 | ||
| HP (n = 3) | Gender (%) | ||
| Male | 2 (66.7) | ||
| Female | 1 (33.3) | ||
| Age | |||
| Mean (min‐max) | 62 (60‐65) | ||
| Medium | 61 | ||
| Plasma | CRC (n = 117) | Gender (%) | |
| Male | 64 (54.7) | ||
| Female | 53 (45.3) | ||
| Age | |||
| Mean (min‐max) | 61.8 (25‐89) | ||
| Medium | 63 | ||
| Control (n = 166) | Gender (%) | ||
| Male | 87 (52.4) | ||
| Female | 79 (47.6) | ||
| Age | |||
| Mean (min‐max) | 36.6 (21‐69) | ||
| Medium | 35 | ||
| AA (n = 23) | Gender (%) | ||
| Male | 11 (47.8) | ||
| Female | 12 (52.2) | ||
| Age | |||
| Mean (min‐max) | 59.4 (46‐61) | ||
| Medium | 60 | ||
| SP (n = 78) | Gender (%) | ||
| Male | 52 (66.7) | ||
| Female | 26 (33.3) | ||
| Age | |||
| Mean (min‐max) | 56.0 (24‐79) | ||
| Medium | 54.5 | ||
Abbreviations: AA, advanced adenomas; CRC, colorectal cancer; HP, hyperplastic polyps; SP, small polyps.